Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
33%
Ph not_applicable
1
33%
Ph phase_4
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
completedearly_phase_1

Photobiomodulation in Combination With Topical Cyclosporine A or Tacrolimus

NCT07239128
unknownnot_applicable

Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo

NCT03365141
unknownphase_4

Topical Tacrolimus in Vernal Keratoconjunctivitis

NCT02456025

Clinical Trials (3)

Showing 3 of 3 trials
NCT07239128Early Phase 1

Photobiomodulation in Combination With Topical Cyclosporine A or Tacrolimus

Completed
NCT03365141Not Applicable

Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo

Unknown
NCT02456025Phase 4

Topical Tacrolimus in Vernal Keratoconjunctivitis

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3